Correlation between transcutaneous bilirubin levels and total serum bilirubin levels in postnatal period in a tertiary care center

Authors

  • Shonit Kantroo Department of Pediatrics, SMBT Institute of Health Sciences and Research Centre, Dhamangaon, Nashik, Maharashtra, India
  • Girish Shakuntal Department of Pediatrics, SMBT Institute of Health Sciences and Research Centre, Dhamangaon, Nashik, Maharashtra, India
  • Vaibhav K. Gode Department of Pediatrics, SMBT Institute of Health Sciences and Research Centre, Dhamangaon, Nashik, Maharashtra, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20230288

Keywords:

Transcutaneous, Bilirubin, Serum, Postnatal

Abstract

Background: Neonatal jaundice is generally a benign condition seen during the postnatal period. The non-invasive methods including transcutaneous bilirubinometry have been developed for assessment of neonatal jaundice, transcutaneous bilirubin TcB) meters noninvasively estimate the bilirubin levels by measuring light transmission through the skin of neonates this value is then to be plotted against a chart in order to look for hyperbilirubinemia. Aim was to determine the efficacy of measuring the transcutaneous bilirubin as a screening tool for clinically significant hyperbilirubinemia.

Methods: Study was a cross sectional study conducted under pediatric department of SMBT IMS and RC at tertiary care center after taking the approval from the ethical committee. Total of 110 neonates that appear to be clinically suffering from neonatal jaundice were considered for study after consent from respective parent/ guardian. Neonatal TCB levels and serum bilirubin levels were done. If bilirubin levels lie in phototherapy range, then baby was shifted to NICU and phototherapy treatment was given, and once levels came within normal range after the phototherapy treatment, again serum bilirubin levels were measured in order to compare pre-and post-treatment levels.

Results: Present study showed male preponderance. 64 were male and 46 were female. Majority 61% were full term normal delivery and 39% were LSCS. Mean TCB level was 8.5±2.8. Statistical significance was seen for TCB and sever hyperbilirubinemia.

Conclusions: Present study concluded that hyperbilirubinemia is commonly seen among males. Newborn delivered had hyperbilirubinemia. Statistical significance was seen between TCB level and severity of the disease.  Thus, neonatal TCB levels can be used as a screening test for detecting hyperbilirubinemia in neonates. As TCB is a noninvasive and cost effective it can be used widely as predictor of the disease.

References

Cat FC, Cat A, Cicek T, Gulec SG. Evaluation of the Relationship Between Transcutaneous Bilirubin Measurement and Total Serum Bilirubin in Neonatal Patients Followed for Jaundice. Sisli Etfal Hastan Tip Bul. 2021;55(2):262-7

Seeralar AT, Ganesh J, Suganya M, Narayana BR, Sathyamoorthi B, Padmanaban S. Correlation between transcutaneous and serum bilirubin measurements in neonates in a tertiary neonatal care center. Int J Contemporary Med Res. 2016;3(8):2340-2.

Bhutani VK, Wong RJ. Bilirubin neurotoxicity in preterm infants: risk and prevention. J Clin Neonatol. 2013;2(2):61-9.

Thakre R. Neonatal hyperbilirubinemia. In: Parthsarathy A, Menon P, editors. IAP Textbook of Pediatrics. 5th ed. Gwalior: Jaypee Brothers. 2013;48-51.

Taylor JA. Discrepancies Between Transcutaneous and Serum Bilirubin Measurements. Pediatrics. 2015;135:224-31

Agrawal G, Garg K, Sitaraman S, Sarna A. Comparison of diagnostic accuracy of different sites for transcutaneous bilirubin measurement in early preterm infants. Indian J Pediatr. 2019;86(1):32-7.

Nahar N, Mannan MA, Dey AC, Ahmed F, Khan KA, Jahan I, et al. Comparison of Serum Bilirubin with Transcutaneous Bilirubinometry in Late Preterm and Term Newborn. Mymensingh Med J. 2017;26(3):621-7.

Khan D, Mirza A, Bhatti A. Effectiveness of Transcutaneous Bilirubin Measurement in High-Risk Neonates and to Evaluate Validity of Transcutaneous Bilirubin with Total Serum Bilirubin Levels in Both Low and High-Risk Neonates at a Tertiary Care Center in a Developing Country. Cureus. 2015;13(3):e13685.

Fouzas S, Mantagou L, Skylogianni E, Mantagos S, Varvarigou A. Transcutaneous bilirubin levels for the first 120 postnatal hours in healthy neonates. Pediatrics. 2010;125(1):e52-7.

Sarici SU, Gunes O, Koklu E, Serdar MA. Transcutaneous Bilirubin Levels during the First Month of Life in Term and Late-preterm Newborns. J Trop Pediatr. 2017;63(1):4-9.

Chimhini GLT, Chimhuya S, Chikwasha V. Evaluation of transcutaneous bilirubinometer (DRAEGER JM 103) use in Zimbabwean newborn babies. Matern Heal Neonatol Perinatol. 2018;4:1.

Sharma AK, Dhawan K, Makkar M, Sharma R. A correlation study between transcutaneous bilirubin and total serum Bilirubin levels among neonates. Asian J Pharm Clin Res. 2022;15(3):15-9.

Downloads

Published

2023-02-01

Issue

Section

Original Research Articles